This Week in Barron's

The January 9th, 2006 edition of Barron's carries a very interesting article (on page 25) suggesting that drug stocks are on the mend, and the prognosis is excellent for the large pharmaceuticals like Pfizer and even Merck. Although we have heard the same sort of rhetoric in the not-so-distant past, evidence shows that the situation may be for real this time!
------------------------------------------
This is also the edition of Barron's that contains the quarterly Barrons/Lipper guide to mutual funds. This is probably the most comprehensive listing of nearly 10,000 mutual funds that is available anywhere.
------------------------------------------
* * * * *